Your browser doesn't support javascript.
loading
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).
Thivat, Emilie; Casile, Mélanie; Moreau, Juliette; Molnar, Ioana; Dufort, Sandrine; Seddik, Khalide; Le Duc, Géraldine; De Beaumont, Olivier; Loeffler, Markus; Durando, Xavier; Biau, Julian.
Afiliação
  • Thivat E; Department of Clinical Research, Délégation Recherche Clinique Et Innovation, Centre Jean Perrin, 58 Rue Montalembert, 63011, Clermont-Ferrand, France. emilie.thivat@clermont.unicancer.fr.
  • Casile M; INSERM U1240 IMoST, Université Clermont Auvergne, Clermont-Ferrand, France. emilie.thivat@clermont.unicancer.fr.
  • Moreau J; UMR 501, Centre d'Investigation Clinique, 63001, Clermont-Ferrand, France. emilie.thivat@clermont.unicancer.fr.
  • Molnar I; Department of Clinical Research, Délégation Recherche Clinique Et Innovation, Centre Jean Perrin, 58 Rue Montalembert, 63011, Clermont-Ferrand, France.
  • Dufort S; INSERM U1240 IMoST, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Seddik K; UMR 501, Centre d'Investigation Clinique, 63001, Clermont-Ferrand, France.
  • Le Duc G; INSERM U1240 IMoST, Université Clermont Auvergne, Clermont-Ferrand, France.
  • De Beaumont O; UMR 501, Centre d'Investigation Clinique, 63001, Clermont-Ferrand, France.
  • Loeffler M; Department of Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
  • Durando X; Department of Clinical Research, Délégation Recherche Clinique Et Innovation, Centre Jean Perrin, 58 Rue Montalembert, 63011, Clermont-Ferrand, France.
  • Biau J; INSERM U1240 IMoST, Université Clermont Auvergne, Clermont-Ferrand, France.
BMC Cancer ; 23(1): 344, 2023 Apr 15.
Article em En | MEDLINE | ID: mdl-37060055
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Nanopartículas Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Nanopartículas Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Female / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França